Structural Imaging Assisted Retinal Fluorescence Lifetime Imager (STARFLI)
NCT ID: NCT05819307
Last Updated: 2023-04-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
70 participants
OBSERVATIONAL
2023-05-01
2024-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Measurement of Retinal Auto Fluorescence With a Fluorescence Lifetime Imaging Ophthalmoscope
NCT01981148
Comparison of a Spectral OCT/SLO With the Stratus OCT for Imaging Various Retinal Pathologies
NCT00408720
High Resolution Retinal Imaging
NCT01866371
Objective Assessment of Macular Function at Retinal and Cortical Levels
NCT03517241
Performance of Long-wavelength Autofluorescence Imaging
NCT03592017
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
OCT/FLIM
OCT/FLIM imaging of the retina
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age: Patients and Probands 18 years or greater
* Both eyes will be assessed in the study
Exclusion Criteria
* Patients younger than 18 years
* Patients with epilepsy
18 Years
120 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Haag-Streit AG
INDUSTRY
University of Bern
OTHER
Insel Gruppe AG, University Hospital Bern
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Martin S. Zinkenagel, Prof.Dr.Dr.
Role: STUDY_CHAIR
Clinic director
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Ophthalmology, Bern University Hospital, Bern, 3010 Bern, Switzerland
Bern, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STARFLI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.